Cargando…

EHMTI-0192. Onabotulinumtoxina prophylaxis in chronic migraine utilization and patient characteristics: observational study in the European Union

Detalles Bibliográficos
Autores principales:	Matharu, M, Pascual, J, Remahl, I Nilsson, Odom, D, Gutierrez, L, Andrews, E, Largent, J, Johannes, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181998/ http://dx.doi.org/10.1186/1129-2377-15-S1-G24

Ejemplares similares

Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe
por: Matharu, Manjit, et al.
Publicado: (2017)

EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
por: Khalil, M, et al.
Publicado: (2014)

EHMTI-0326. OnabotulinumtoxinA for the treatment of chronic paroxysmal hemicrania: a case report
por: Dolezil, D
Publicado: (2014)

EHMTI-0065. Effects of antiepileptic drugs on spreading depression in the chick retina: implications for migraine prophylaxis
por: Mascarenhas de Moraes, J, et al.
Publicado: (2014)

EHMTI-0146. Topiramate in migraine prevention
por: Ristic, S, et al.
Publicado: (2014)

EHMTI-0191. A novel approach for the treatment of cluster headache – onabotulinumtoxina block of the sphenopalatine ganglion
por: Bratbak, D, et al.
Publicado: (2014)

EHMTI-0086. Pure mestrual vestibular migraine
por: Mostardini, C, et al.
Publicado: (2014)

EHMTI-0049. Headache, migraine and epileptic seizures
por: Gligic, N, et al.
Publicado: (2014)

EHMTI-0089. Relationship of sleep bruxism and migraine
por: Kato, M, et al.
Publicado: (2014)

EHMTI-0111. Intra-variability of migraine attacks features
por: Viana, M, et al.
Publicado: (2014)

EHMTI-0122. Serum micrornas as potential biomarkers of migraine
por: Andersen, HH, et al.
Publicado: (2014)

EHMTI-0107. Treatment of migraine in Croatia, year 2013
por: Cvetkovic, V Vukovic, et al.
Publicado: (2014)

EHMTI-0358. Improved chronic migraine after DTMS
por: Scatena, P, et al.
Publicado: (2014)

EHMTI-0348. Refractive errors in patients with migraine headache
por: Gunes, A, et al.
Publicado: (2014)

EHMTI-0050. Systemic and cerebral endothelial function in migraine
por: Zaletel, M, et al.
Publicado: (2014)

EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients
por: Majláth, Z, et al.
Publicado: (2014)

EHMTI-0070. Effect of occlusal sprint in migraine patients
por: Takeuchi, M, et al.
Publicado: (2014)

EHMTI-0374. Gene-based pleiotropy across migraine with and migraine without aura
por: Nyholt, D, et al.
Publicado: (2014)

EHMTI-0230. Characteristics of menstrual and nonmenstrual migraine attacks in women with menstrual migraine
por: Vetvik, KG, et al.
Publicado: (2014)

EHMTI-0105. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine
por: Cernuda-Morollón, E, et al.
Publicado: (2014)

EHMTI-0249. Headache attributed to hypertension in chronic migraine patients
por: Grosu, O, et al.
Publicado: (2014)

EHMTI-0080. How migraine is affected by therapies for multiple sclerosis
por: Condello, C, et al.
Publicado: (2014)

EHMTI-0030. Migraine pain location in adult: the bangladeshi experience
por: Haque, R
Publicado: (2014)

EHMTI-0194. The impact of dizziness in tertiary care migraine patients
por: Sugrue, J, et al.
Publicado: (2014)

EHMTI-0044. Variability of clinical features in attacks of migraine with aura
por: Hansen, J Møller, et al.
Publicado: (2014)

EHMTI-0037. Botulinum A toxin for treatment of chronic migraine
por: Grazzi, L, et al.
Publicado: (2014)

EHMTI-0055. Abnormal thalamic function in patients with vestibular migraine
por: Russo, A, et al.
Publicado: (2014)

EHMTI-0206. Nigerian plants that are used for treatment of headache and migraine
por: Saganuwan, SA
Publicado: (2014)

EHMTI-0313. Factors influencing stigma towards persons with migraine
por: Shapiro, RE, et al.
Publicado: (2014)

EHMTI-0377. The influence of genetic constitution on migraine drug responses
por: Christensen, AF, et al.
Publicado: (2014)

EHMTI-0104. VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine
por: Cernuda-Morollón, E, et al.
Publicado: (2014)

EHMTI-0380. The association of migraine susceptibility loci with severe migraine characteristics in a clinic-based migraine sample
por: Esserlind, A, et al.
Publicado: (2014)

EHMTI-0108. Efficacy of therapy in patients with migraine: comparison in group of < 9 migraines and > 10 migraines per month
por: Cvetkovic, V Vukovic, et al.
Publicado: (2014)

EHMTI-0039. Different efficacy of acute migraine therapies for migraine with aura versus without aura
por: Hansen, J Møller, et al.
Publicado: (2014)

EHMTI-0188. Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine
por: MacGregor, EA, et al.
Publicado: (2014)

EHMTI-0115. Migraine under 7 years: a clinical study
por: Pitino, R, et al.
Publicado: (2014)

EHMTI-0048. Epigenetic changes in a rat model of migraine with aura
por: Vila-Pueyo, M, et al.
Publicado: (2014)

EHMTI-0298. Relationship between migraine and abnormal EEG findings in children
por: Karimzadeh, P
Publicado: (2014)

EHMTI-0371. A new physical sign in migraine 'pointing forehead'
por: Samarakoon, S, et al.
Publicado: (2014)

EHMTI-0328. Comparative evaluation of pregabalin, gabapentin, carbamazepine and topiramat in migraine
por: Axelerad, A Docu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ic01kl6n3uhv3togsk9743gpu9